HIGH

Fagron Compounding Services Vancomycin HCl 1 g in 250 mL NS Injection Recall Expands in 2026

Fagron Compounding Services is recalling 11,680 bags of Vancomycin HCl 1 g in 250 mL 0.9% Sodium Chloride Injection. The recall is nationwide in the United States. The blue break-off part could detach from the administration port, raising sterility concerns. Stop using immediately and contact the provider for guidance.

Quick Facts at a Glance

Recall Date
March 20, 2026
Hazard Level
HIGH
Brand
Fagron Compounding Services
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

Hazard Information

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

This product is a compounded IV antibiotic prepared by a compounding pharmacy for clinical use. Healthcare settings rely on such products for sterile administration.

Why This Is Dangerous

Break-Off-Part detachment could compromise sterility and introduce contaminants into IV administration.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

High urgency for healthcare facilities to review inventory, discontinue use, and contact the supplier for guidance.

Practical Guidance

How to identify if yours is affected

  1. Review lot numbers against the recall list: C274-000050987, C274-000049425, C274-000050069, C274-000050346, C274-000050698, C274-000050699, C274-000050775.
  2. Check Expiration Dates (through 7/12/2026, 5/2/2026, 5/30/2026, 6/10/2026, 6/27/2026, 7/4/2026).
  3. Inspect the blue Break-Off-Part and administration port for detachment signs.

Where to find product info

FDA recall page D-0442-2026 and recall letter from Fagron Compounding Services.

What timeline to expect

Immediate action required; replacements or refunds arranged through recall notification.

If the manufacturer is unresponsive

  • Escalate to hospital recall coordinator
  • Contact FDA through recall portal if manufacturer is non-responsive
  • Consult legal counsel if needed

How to prevent similar issues

  • Verify sterility assurance during compounding
  • Use commercially manufactured IV products where possible
  • Enhance receiving inspections for sterile IV bags

Documentation advice

Document lot numbers checked, dates, communications with supplier, and disposition of each bag.

Product Details

Product: Vancomycin HCl 1 g added to 250 mL 0.9% Sodium Chloride Injection USP. Manufacturer: Fagron Sterile Services. Address: 8710 34th St. N. Wichita, KS 67226. NDC: 71266-5082-01. Distribution: Nationwide in the USA. Recall date: 2026-03-20. Report date: 2026-04-15. Status: Active. Quantity: 11,680 bags. Lot numbers and expirations include: C274-000050987 Exp. 7/12/2026; C274-000049425 Exp. 5/2/2026; C274-000050069 Exp. 5/30/2026; C274-000050346 Exp. 6/10/2026; C274-000050698 Exp. 6/27/2026; C274-000050699 Exp. 6/27/2026; C274-000050775 Exp. 7/4/2026.

Reported Incidents

No incident or injury counts are provided in the notice. The FDA listing indicates a Class II recall with a high hazard potential.

Key Facts

  • 11,680 bags recalled
  • Nationwide distribution in the USA
  • Blue Break-Off-Part detachment risk
  • NDC 71266-5082-01
  • Lots include C274-000050987, C274-000049425, C274-000050069, C274-000050346, C274-000050698, C274-0

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTELDERLYINFANTSCHILDRENPETS
Injury Types
POISONINGELECTRICALBURNOTHER

Product Classification

Product Details

Model Numbers
Lot: C274-000050987 Exp.:7/12/2026
Lot: C274-000049425 Exp.:5/2/2026
Lot: C274-000050069 Exp.:5/30/2026
Lot: C274-000050346 Exp.:6/10/2026
Lot: C274-000050698 Exp.:6/27/2026
+2 more
Affected States
ALL
Report Date
April 15, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more